2014
DOI: 10.1007/s40292-014-0071-2
|View full text |Cite
|
Sign up to set email alerts
|

2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: What Has Changed in Daily Clinical Practice?

Abstract: This is a review article aiming to make focus on the changes made in the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines for the management of arterial hypertension with some criticism for each element discussed in the text. Given that in the real world clinical practice physicians would hardly spend the time needed for studying the 77 pages manuscript of the recently released 2013 ESH/ESC hypertension guidelines, the present review summarizes all the significant updates … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…dyslipidemia was defined according to the ESC recommendations (Guidelines for the Management of Dyslipidemias). [7][8][9] The degrees of stenosis of the common carotid artery and/or internal carotid artery were assessed according to the NASCET criteria. [10] Blood BDNF, Il-2, IL-6, S100B, TNF, GRN, NSE, uPA, VEGF concentrations on day 1 of stroke were assessed according to procedure as follows: 7 ml of EDTA blood was drawn and plasma was obtained after 15 minutes of centrifugation (1500 rpm), then the plasma was frozen at -80°C.…”
Section: Methodsmentioning
confidence: 99%
“…dyslipidemia was defined according to the ESC recommendations (Guidelines for the Management of Dyslipidemias). [7][8][9] The degrees of stenosis of the common carotid artery and/or internal carotid artery were assessed according to the NASCET criteria. [10] Blood BDNF, Il-2, IL-6, S100B, TNF, GRN, NSE, uPA, VEGF concentrations on day 1 of stroke were assessed according to procedure as follows: 7 ml of EDTA blood was drawn and plasma was obtained after 15 minutes of centrifugation (1500 rpm), then the plasma was frozen at -80°C.…”
Section: Methodsmentioning
confidence: 99%
“…Initially, the criteria were met by 61 patients, 29 patients were enrolled in the study, and the results of 13 patients were included in the preparatory analysis presented in the preliminary report. All the patients included in the study were analyzed according to: their age at the first-in-life stroke onset; the presence of comorbidities such as: atrial fibrillation (AF), arterial hypertension (AH), coronary heart disease (CHD), diabetes mellitus (DM) and lipid disorders (LD), >70% atherosclerotic carotid stenosis (ipsilaterally to the acute ischemic brain lesion) according to NASCET [2]; their neurological status on the first day after stroke onset evaluated according to the National Institute of Health Stroke Scale (NIHSS) [3]; the location of the stroke (total anterior cerebral infarct, TACI); partial anterior CI (PACI), lacunar CI (LACI) and posterior CI (POCI) [4]; early therapeutic management in the acute stage of stroke (recombinant tissue plasminogen activator [iv rtPA], endovascular, antiplatelet treatment); their functional status at 14 days after stroke according to mRS [5]. fMRI of the head up to 4th day of stroke…”
Section: Methodsmentioning
confidence: 99%
“…The eGFR calculation obtained from SC was based on the Levey modified Modification of Diet in Renal Disease formula as 186 × SC −1.154 × age −0.203 × 0.742 (if female) (Foundation National Kidney, 2002). A systolic blood pressure > 140/ 90 mm Hg obtained by at least two separate measurements during hospitalization, a previously diagnosed hypertension or history of antihypertensive medications was regarded as hypertension (Liakos et al, 2015;Mancia et al, 2007), while DM was defined as either preexisting diagnosed disease or at least two fasting blood glucose levels higher than 7.0 mmol/l or two-hour plasma glucose levels higher than 11.1 mmol/l by oral glucose tolerance test (Ryden et al, 2007). CIAKI referred to an absolute increase of 0.5 mg/dl (44.2 µmol/l) and/or a 25% increase in SC concentration from baseline value of contrast agent administration to 72 h in the absence of alternative explanation for acute kidney injury (AKI) (Silvain et al, 2014).…”
Section: Study Protocolmentioning
confidence: 99%